basaglar tempo pen

Generic: insulin glargine

Labeler: eli lilly and company
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name basaglar tempo pen
Generic Name insulin glargine
Labeler eli lilly and company
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

insulin glargine 100 [iU]/mL

Manufacturer
Eli Lilly and Company

Identifiers & Regulatory

Product NDC 0002-8214
Product ID 0002-8214_3c2283e6-2844-44d2-a447-579b07e77c27
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA205692
Marketing Start 2015-12-16
Marketing End 2026-07-27

Pharmacologic Class

Established (EPC)
insulin analog [epc]
Chemical Structure
insulin [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00028214
Hyphenated Format 0002-8214

Supplemental Identifiers

RxCUI
847230 1736863 2268064 2268065
UNII
2ZM8CX04RZ
NUI
M0011417 N0000175453

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name basaglar tempo pen (source: ndc)
Generic Name insulin glargine (source: ndc)
Application Number BLA205692 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 100 [iU]/mL
source: ndc
Packaging
  • 5 SYRINGE in 1 CARTON (0002-8214-05) / 3 mL in 1 SYRINGE (0002-8214-01)
source: ndc

Packages (1)

0002-8214-05 5 SYRINGE in 1 CARTON (0002-8214-05) / 3 mL in 1 SYRINGE (0002-8214-01)

Ingredients (1)

insulin glargine (100 [iU]/mL)

Linked Drug Pages (1)

BASAGLAR KwikPen, BASAGLAR Tempo Pen ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "3c2283e6-2844-44d2-a447-579b07e77c27", "openfda": {"nui": ["M0011417", "N0000175453"], "unii": ["2ZM8CX04RZ"], "rxcui": ["847230", "1736863", "2268064", "2268065"], "spl_set_id": ["0ad21db3-2b1c-4ed9-a687-bdd6a74d0aae"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 SYRINGE in 1 CARTON (0002-8214-05)  / 3 mL in 1 SYRINGE (0002-8214-01)", "package_ndc": "0002-8214-05", "marketing_end_date": "20260727", "marketing_start_date": "20191115"}], "brand_name": "BASAGLAR Tempo Pen", "product_id": "0002-8214_3c2283e6-2844-44d2-a447-579b07e77c27", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Insulin Analog [EPC]", "Insulin [CS]"], "product_ndc": "0002-8214", "generic_name": "Insulin glargine", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BASAGLAR", "brand_name_suffix": "Tempo Pen", "active_ingredients": [{"name": "INSULIN GLARGINE", "strength": "100 [iU]/mL"}], "application_number": "BLA205692", "marketing_category": "BLA", "marketing_end_date": "20260727", "marketing_start_date": "20151216"}